These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2566960)

  • 1. [Growth hormone-releasing hormone. The physiopathologic aspects and its diagnostic-therapeutic use].
    De Marinis L; Mancini A; La Brocca A; D'Amico C; Sambo P; Tofani A; Barbarino A
    Minerva Med; 1989 Apr; 80(4):325-34. PubMed ID: 2566960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of human growth hormone and its secretagogues.
    Root AW; Root MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.
    Bercu BB; Yang SW; Masuda R; Walker RF
    Endocrinology; 1992 May; 130(5):2579-86. PubMed ID: 1315249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-hormone-releasing hormone.
    Vance ML
    Clin Chem; 1990 Mar; 36(3):415-20. PubMed ID: 2107038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies with GHRH in man.
    Thorner MO; Vance ML; Evans WS; Rogol AD; Rivier J; Vale W; Blizzard RM
    Horm Res; 1986; 24(2-3):91-8. PubMed ID: 3093355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children.
    Ross RJ; Grossman A; Besser GM; Savage MO
    Acta Endocrinol Suppl (Copenh); 1986; 279():123-9. PubMed ID: 3096037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of growth hormone-releasing factor (GRF) activity in the pituitary and hypothalamus of the conscious rat with a peptidic GRF antagonist.
    Lumpkin MD; McDonald JK
    Endocrinology; 1989 Mar; 124(3):1522-31. PubMed ID: 2537185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone releasing hormone.
    Grossman A; Savage MO; Besser GM
    Clin Endocrinol Metab; 1986 Aug; 15(3):607-27. PubMed ID: 2429796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that ghrelin is as potent as growth hormone (GH)-releasing hormone (GHRH) in releasing GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH.
    Kineman RD; Luque RM
    Endocrinology; 2007 Sep; 148(9):4440-9. PubMed ID: 17540720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
    Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
    Kamegai J; Unterman TG; Frohman LA; Kineman RD
    Endocrinology; 1998 Aug; 139(8):3554-60. PubMed ID: 9681507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone secretagogues as diagnostic tools in disease states.
    Baldelli R; Otero XL; Camiña JP; Gualillo O; Popovic V; Dieguez C; Casanueva FF
    Endocrine; 2001 Feb; 14(1):95-9. PubMed ID: 11322508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
    Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.